SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-168597
Filing Date
2024-06-26
Accepted
2024-06-26 08:32:21
Documents
53
Period of Report
2024-06-26
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d808272d8k.htm   iXBRL 8-K 30635
2 EX-99.1 d808272dex991.htm EX-99.1 26523
3 EX-99.2 d808272dex992.htm EX-99.2 41923
7 GRAPHIC g808272ex99_2p10g1.jpg GRAPHIC 215296
8 GRAPHIC g808272ex99_2p11g1.jpg GRAPHIC 261344
9 GRAPHIC g808272ex99_2p12g1.jpg GRAPHIC 232097
10 GRAPHIC g808272ex99_2p13g1.jpg GRAPHIC 121445
11 GRAPHIC g808272ex99_2p14g1.jpg GRAPHIC 166317
12 GRAPHIC g808272ex99_2p15g1.jpg GRAPHIC 387595
13 GRAPHIC g808272ex99_2p16g1.jpg GRAPHIC 336610
14 GRAPHIC g808272ex99_2p17g1.jpg GRAPHIC 291542
15 GRAPHIC g808272ex99_2p18g1.jpg GRAPHIC 339843
16 GRAPHIC g808272ex99_2p19g1.jpg GRAPHIC 174395
17 GRAPHIC g808272ex99_2p1g1.jpg GRAPHIC 232762
18 GRAPHIC g808272ex99_2p20g1.jpg GRAPHIC 192874
19 GRAPHIC g808272ex99_2p21g1.jpg GRAPHIC 254392
20 GRAPHIC g808272ex99_2p22g1.jpg GRAPHIC 250378
21 GRAPHIC g808272ex99_2p23g1.jpg GRAPHIC 212608
22 GRAPHIC g808272ex99_2p24g1.jpg GRAPHIC 308094
23 GRAPHIC g808272ex99_2p25g1.jpg GRAPHIC 338858
24 GRAPHIC g808272ex99_2p26g1.jpg GRAPHIC 312399
25 GRAPHIC g808272ex99_2p27g1.jpg GRAPHIC 322420
26 GRAPHIC g808272ex99_2p28g1.jpg GRAPHIC 439382
27 GRAPHIC g808272ex99_2p29g1.jpg GRAPHIC 537489
28 GRAPHIC g808272ex99_2p2g1.jpg GRAPHIC 750512
29 GRAPHIC g808272ex99_2p30g1.jpg GRAPHIC 469346
30 GRAPHIC g808272ex99_2p31g1.jpg GRAPHIC 374919
31 GRAPHIC g808272ex99_2p32g1.jpg GRAPHIC 201298
32 GRAPHIC g808272ex99_2p33g1.jpg GRAPHIC 282384
33 GRAPHIC g808272ex99_2p34g1.jpg GRAPHIC 306698
34 GRAPHIC g808272ex99_2p35g1.jpg GRAPHIC 380749
35 GRAPHIC g808272ex99_2p36g1.jpg GRAPHIC 241463
36 GRAPHIC g808272ex99_2p37g1.jpg GRAPHIC 162750
37 GRAPHIC g808272ex99_2p3g1.jpg GRAPHIC 210594
38 GRAPHIC g808272ex99_2p4g1.jpg GRAPHIC 497152
39 GRAPHIC g808272ex99_2p5g1.jpg GRAPHIC 257095
40 GRAPHIC g808272ex99_2p6g1.jpg GRAPHIC 342990
41 GRAPHIC g808272ex99_2p7g1.jpg GRAPHIC 297047
42 GRAPHIC g808272ex99_2p8g1.jpg GRAPHIC 298786
43 GRAPHIC g808272ex99_2p9g1.jpg GRAPHIC 274338
44 GRAPHIC g808272g0626050047738.jpg GRAPHIC 3099
  Complete submission text file 0001193125-24-168597.txt   15782685

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lyel-20240626.xsd EX-101.SCH 2832
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyel-20240626_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyel-20240626_pre.xml EX-101.PRE 10800
56 EXTRACTED XBRL INSTANCE DOCUMENT d808272d8k_htm.xml XML 3508
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40502 | Film No.: 241070704
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)